Julia M. Assini

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Julia M. Assini, Justin K. Lee et al. · Diabetes · 2011 · 200 citations · Full text

Naringenin Decreases Progression of Atherosclerosis by Improving Dyslipidemia in High-Fat–Fed Low-Density Lipoprotein Receptor–Null Mice

Erin E. Mulvihill, Julia M. Assini, Brian G. Sutherland et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 162 citations

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr mice

Julia M. Assini, Erin E. Mulvihill, Brian G. Sutherland et al. · Journal of Lipid Research · 2012 · 135 citations · Full text

Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21

Julia M. Assini, Erin E. Mulvihill, Amy C. Burke et al. · Endocrinology · 2015 · 113 citations

LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study

Alexandria M. Doerfler, So Hyun Park, Julia M. Assini et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 32 citations · Full text

Lpa Disruption, Knockout Mouse, Transgenic Mouse Models +13